{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:59:44Z","timestamp":1793771984926,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This work was supported in part by The Kerry and Simone Vickar Family Foundation and the Leon Levine Foundation."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41375-019-0567-9","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T17:02:49Z","timestamp":1567011769000},"page":"369-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations"],"prefix":"10.1038","volume":"34","author":[{"given":"Amanda","family":"Lance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Druhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Greer","family":"Vestal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nury M.","family":"Steuerwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Tjaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andee N.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda R.","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"567_CR1","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","volume":"368","author":"JE Maxson","year":"2013","unstructured":"Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. New Engl J Med. 2013;368:1781\u201390.","journal-title":"New Engl J Med"},{"key":"567_CR2","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1182\/blood-2016-04-709899","volume":"127","author":"JE Maxson","year":"2016","unstructured":"Maxson JE, Ries RE, Wang YC, Gerbing RB, Kolb EA, Thompson SL, et al. CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML. Blood. 2016;127:3094\u20138.","journal-title":"Blood"},{"key":"567_CR3","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/leu.2013.122","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013;27:1870\u20133.","journal-title":"Leukemia"},{"key":"567_CR4","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1182\/blood-2012-01-406116","volume":"119","author":"R Beekman","year":"2012","unstructured":"Beekman R, Valkhof MG, Sanders MA, van Strien PM, Haanstra JR, Broeders L, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012;119:5071\u20137.","journal-title":"Blood"},{"key":"567_CR5","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2007-03-081216","volume":"110","author":"DC Link","year":"2007","unstructured":"Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, et al. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood. 2007;110:1648\u201355.","journal-title":"Blood"},{"key":"567_CR6","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1002\/j.1460-2075.1991.tb07835.x","volume":"10","author":"R Fukunaga","year":"1991","unstructured":"Fukunaga R, Ishizaka-Ikeda E, Pan CX, Seto Y, Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1991;10:2855\u201365.","journal-title":"EMBO J"},{"key":"567_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood.V88.3.761.bloodjournal883761","volume":"88","author":"BR Avalos","year":"1996","unstructured":"Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 1996;88:761\u201377.","journal-title":"Blood"},{"key":"567_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","volume":"46","author":"P Dwivedi","year":"2017","unstructured":"Dwivedi P, Greis KD. Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies. Exp Hematol. 2017;46:9\u201320.","journal-title":"Exp Hematol"},{"key":"567_CR9","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood.V95.11.3335","volume":"95","author":"SM White","year":"2000","unstructured":"White SM, Alarcon MH, Tweardy DJ. Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform. Blood. 2000;95:3335\u201340.","journal-title":"Blood"},{"key":"567_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/leu.2013.321","volume":"28","author":"HM Mehta","year":"2014","unstructured":"Mehta HM, Futami M, Glaubach T, Lee DW, Andolina JR, Yang Q, et al. Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition. Leukemia. 2014;28:1041\u201351.","journal-title":"Leukemia"},{"key":"567_CR11","doi-asserted-by":"publisher","first-page":"14483","DOI":"10.1073\/pnas.0605245103","volume":"103","author":"EM Sloand","year":"2006","unstructured":"Sloand EM, Yong AS, Ramkissoon S, Solomou E, Bruno TC, Kim S, et al. Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. PNAS. 2006;103:14483\u20138.","journal-title":"PNAS"},{"key":"567_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2119\/molmed.2014.00146","volume":"20","author":"H Zhang","year":"2015","unstructured":"Zhang H, Goudeva L, Immenschuh S, Schambach A, Skokowa J, Eiz-Vesper B, et al. miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34(+) progenitor cells. Mol Med. 2015;20:736\u201346.","journal-title":"Mol Med"},{"key":"567_CR13","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1200\/JCO.2009.25.9010","volume":"28","author":"S Ehlers","year":"2010","unstructured":"Ehlers S, Herbst C, Zimmermann M, Scharn N, Germeshausen M, von Neuhoff N, et al. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28:2591\u20137.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"567_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/0092-8674(93)90729-A","volume":"74","author":"R Fukunaga","year":"1993","unstructured":"Fukunaga R, Ishizaka-Ikeda E, Nagata S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell. 1993;74:1079\u201387.","journal-title":"Cell"},{"key":"567_CR15","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/leu.2013.182","volume":"27","author":"O Kosmider","year":"2013","unstructured":"Kosmider O, Itzykson R, Chesnais V, Lasho T, Laborde R, Knudson R, et al. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia. Leukemia. 2013;27:1946\u20139.","journal-title":"Leukemia"},{"key":"567_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","volume":"1","author":"A Tefferi","year":"2016","unstructured":"Tefferi A, Lasho TL, Guglielmelli P, Finke CM, Rotunno G, Elala Y, et al. Targeted deep sequencing in polycythemia vera and essential thrombocythemia. Blood Adv. 2016;1:21\u201330.","journal-title":"Blood Adv"},{"issue":"Aug","key":"567_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2013.06.052","volume":"154","author":"JJ Wong","year":"2013","unstructured":"Wong JJ, Ritchie W, Ebner OA, Selbach M, Wong JW, Huang Y, et al. Orchestrated intron retention regulates normal granulocyte differentiation. Cell. 2013;154(Aug):583\u201395.","journal-title":"Cell"},{"key":"567_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.stem.2018.03.012","volume":"22","author":"M Cesana","year":"2018","unstructured":"Cesana M, Guo MH, Cacchiarelli D, Wahlster L, Barragan J, Doulatov S, et al. A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development. Cell Stem Cell. 2018;22:575\u201388 e577.","journal-title":"Cell Stem Cell"},{"key":"567_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1118-6","volume":"17","author":"A Nellore","year":"2016","unstructured":"Nellore A, Jaffe AE, Fortin JP, Alquicira-Hernandez J, Collado-Torres L, Wang S, et al. Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the sequence read archive. Genome Biol. 2016;17:266.","journal-title":"Genome Biol"},{"key":"567_CR20","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1182\/blood-2002-07-2062","volume":"101","author":"MH Hermans","year":"2003","unstructured":"Hermans MH, van de Geijn GJ, Antonissen C, Gits J, van Leeuwen D, Ward AC, et al. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood. 2003;101:2584\u201390.","journal-title":"Blood"},{"key":"567_CR21","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791","volume":"78","author":"GD Demetri","year":"1991","unstructured":"Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78:2791\u2013808.","journal-title":"Blood"},{"key":"567_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1182\/blood.V85.3.799.bloodjournal853799","volume":"85","author":"N Berliner","year":"1995","unstructured":"Berliner N, Hsing A, Graubert T, Sigurdsson F, Zain M, Bruno E, et al. Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood. 1995;85:799\u2013803.","journal-title":"Blood"},{"key":"567_CR23","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.4049\/jimmunol.173.8.5036","volume":"173","author":"MG Hunter","year":"2004","unstructured":"Hunter MG, Jacob A, O\u2019Donnell LC, Agler A, Druhan LJ, Coggeshall KM, et al. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia\/acute myelogenous leukemia. J Immunol. 2004;173:5036\u201345.","journal-title":"J Immunol"},{"key":"567_CR24","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.4049\/jimmunol.160.10.4979","volume":"160","author":"MG Hunter","year":"1998","unstructured":"Hunter MG, Avalos BR. Phosphatidylinositol 3\u2019-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol. 1998;160:4979\u201387.","journal-title":"J Immunol"},{"key":"567_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4049\/jimmunol.169.3.1219","volume":"169","author":"M Hortner","year":"2002","unstructured":"Hortner M, Nielsch U, Mayr LM, Johnston JA, Heinrich PC, Haan S. Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol. 2002;169:1219\u201327.","journal-title":"J Immunol"},{"key":"567_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1158\/1078-0432.CCR-14-3100","volume":"22","author":"JE Maxson","year":"2016","unstructured":"Maxson JE, Luty SB, MacManiman JD, Paik JC, Gotlib J, Greenberg P, et al. The colony-stimulating factor 3 receptor T640N mutation is oncogenic, sensitive to JAK inhibition, and mimics T618I. Clin Cancer Res. 2016;22:757\u201364.","journal-title":"Clin Cancer Res"},{"key":"567_CR27","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood.V88.4.1234.bloodjournal8841234","volume":"88","author":"LT Smith","year":"1996","unstructured":"Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C\/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996;88:1234\u201347.","journal-title":"Blood"},{"key":"567_CR28","first-page":"137","volume":"211","author":"DE Zhang","year":"1996","unstructured":"Zhang DE, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ, et al. Function of PU.1 (Spi-1), C\/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr Top Microbiol Immunol. 1996;211:137\u201347.","journal-title":"Curr Top Microbiol Immunol"},{"key":"567_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/sci.2018.08.02","volume":"5","author":"Y Gao","year":"2018","unstructured":"Gao Y, Vasic R, Halene S. Role of alternative splicing in hematopoietic stem cells during development. Stem Cell Invest. 2018;5:26.","journal-title":"Stem Cell Invest"},{"key":"567_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.stemcr.2016.12.002","volume":"8","author":"O Goldstein","year":"2017","unstructured":"Goldstein O, Meyer K, Greenshpan Y, Bujanover N, Feigin M, Ner-Gaon H, et al. Mapping whole-transcriptome splicing in mouse hematopoietic stem cells. Stem Cell Rep. 2017;8:163\u201376.","journal-title":"Stem Cell Rep"},{"key":"567_CR31","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood-2017-02-692715","volume":"129","author":"P Joshi","year":"2017","unstructured":"Joshi P, Halene S, Abdel-Wahab O. How do messenger RNA splicing alterations drive myelodysplasia? Blood. 2017;129:2465\u201370.","journal-title":"Blood"},{"key":"567_CR32","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1182\/blood-2016-10-692400","volume":"129","author":"B Saez","year":"2017","unstructured":"Saez B, Walter MJ, Graubert TA. Splicing factor gene mutations in hematologic malignancies. Blood. 2017;129:1260\u20139.","journal-title":"Blood"},{"key":"567_CR33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1158\/1078-0432.CCR-13-0956","volume":"20","author":"S Adamia","year":"2014","unstructured":"Adamia S, Haibe-Kains B, Pilarski PM, Bar-Natan M, Pevzner S, Avet-Loiseau H, et al. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res. 2014;20:1135\u201345.","journal-title":"Clin Cancer Res"},{"key":"567_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","volume":"27","author":"E Kim","year":"2015","unstructured":"Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell. 2015;27:617\u201330.","journal-title":"Cancer Cell"},{"key":"567_CR35","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41375-018-0152-7","volume":"32","author":"Y Liang","year":"2018","unstructured":"Liang Y, Tebaldi T, Rejeski K, Joshi P, Stefani G, Taylor A, et al. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells. Leukemia. 2018;32:2659\u201371.","journal-title":"Leukemia"},{"key":"567_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.55","volume":"3","author":"J Menezes","year":"2013","unstructured":"Menezes J, Makishima H, Gomez I, Acquadro F, Gomez-Lopez G, Grana O, et al. CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. Blood Cancer J. 2013;3:e158.","journal-title":"Blood Cancer J"},{"key":"567_CR37","doi-asserted-by":"publisher","first-page":"E4726","DOI":"10.1073\/pnas.1514105112","volume":"112","author":"J Zhang","year":"2015","unstructured":"Zhang J, Lieu YK, Ali AM, Penson A, Reggio KS, Rabadan R, et al. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. PNAS. 2015;112:E4726\u20134734.","journal-title":"PNAS"},{"key":"567_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","volume":"132","author":"A Pellagatti","year":"2018","unstructured":"Pellagatti A, Armstrong RN, Steeples V, Sharma E, Repapi E, Singh S, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations. Blood. 2018;132:1225\u201340.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0567-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T18:07:32Z","timestamp":1721671652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0567-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0567-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}